leisure time -WSS

leisure time

author：leisure time 2025-09-29 22:51:47 - browse：738

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

WSS

How doctors’ personal politics affect patients

Senate panel puts off hardest PBM reforms for another day

Humana, CVS hope to turn members into patients at clinics

A new crop of companies is reshaping the health data economy

Biden calls for immediate release of Niger's president amid apparent coup

What Henrietta Lacks settlement says about racism in medicine

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New lawsuit accuses health insurer Cigna of denying claims in bulk

In Memoriam: Notable people who died in 2023

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

23andMe had bad news about my health. I wish a person had delivered it

The battle over 'scope creep' and who gets to be called 'doctor'

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What Henrietta Lacks settlement says about racism in medicine

Heart attack and stroke risk calculators need revising

What causes rare myocarditis in young men after Covid vaccines?

hotspot

What to watch for from Zogenix and Amicus clinical trials

Microsoft strikes partnership with Duke Health to advance health AI

Attacks on the drug industry will lead to fewer breakthroughs

Former reverend arrested for allegedly killing 8

The drug industry sees a key ally in the Senate prevail

What the cancer research community can learn from the Covid response

leisure time

focus

hotspot

entertainment